David Mountcastle Sells 24,734 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 24,734 shares of the company’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total transaction of $680,185.00. Following the transaction, the chief financial officer directly owned 186,728 shares of the company’s stock, valued at approximately $5,135,020. This trade represents a 11.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The shares were sold at an average price of $25.18, for a total value of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The shares were sold at an average price of $22.60, for a total value of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $179,690.37.

Privia Health Group Stock Down 0.1%

Shares of Privia Health Group stock opened at $27.21 on Thursday. The business has a 50 day moving average of $23.65 and a 200 day moving average of $23.08. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $27.70. The company has a market cap of $3.43 billion, a PE ratio of 170.07, a P/E/G ratio of 2.15 and a beta of 0.83.

Institutional Investors Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently bought and sold shares of PRVA. GAMMA Investing LLC boosted its position in shares of Privia Health Group by 14.0% in the 2nd quarter. GAMMA Investing LLC now owns 4,819 shares of the company’s stock worth $124,000 after purchasing an additional 592 shares in the last quarter. Harbor Investment Advisory LLC bought a new position in Privia Health Group during the 2nd quarter valued at approximately $69,000. Central Pacific Bank Trust Division raised its stake in Privia Health Group by 456.5% during the second quarter. Central Pacific Bank Trust Division now owns 7,001 shares of the company’s stock valued at $180,000 after buying an additional 5,743 shares during the last quarter. Alpine Woods Capital Investors LLC bought a new stake in Privia Health Group in the first quarter worth $231,000. Finally, Edgestream Partners L.P. bought a new stake in Privia Health Group in the first quarter worth $2,847,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on PRVA shares. Canaccord Genuity Group cut their target price on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 2nd. Evercore set a $26.00 target price on Privia Health Group in a report on Wednesday, April 8th. Finally, Barclays lowered their target price on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Eleven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average target price of $31.15.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.